-
Horizon Pharma (HZNP): Raising PT On RPTP Deal - Mizuho
-
HZNP INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Horizon Pharma PLC
-
Leerink Highlights Top 10 Biopharma Stocks for Partnerships & Acquisitions
-
HZNP INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Horizon Pharma PLC
-
Major drugmakers push back in U.S. price debate
-
Valeant's looming M&A hiatus deals blow to investment banks
-
Valeant vows to refute 'phantom sales' allegations
-
Depomed (DEPO) Comments on Negative Horizon Pharma (HZNP) News; Had Speculated About Business Model
-
Depomed Comments on Recent Reports Regarding Horizon Pharma's Business Model
-
Mizuho Weighs in on Panic in Specialty Pharmaceuticals Sector (VRX) (AGN) (ENDP) (SCMP) (JAZZ) (MNK)
-
UPDATE: Horizon Pharma (HZNP) Seen as More Risky, Downgraded to Hold at Brean Capital
-
Depomed's (DEPO) Board Rejects Horizon Pharma's (HZNP) Unsolicited Exchange Offer
-
Depomed's Board of Directors Rejects Horizon Pharma plc's Unsolicited Exchange Offer
-
Depomed (DEPO) Board Rejects Horizon Pharma's (HZNP) Revised Takeover Proposal
-
Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc
-
Horizon Pharma (HZNP) Reports DUEXIS and VIMOVO No Longer on Formularies at Caremark and ESI
-
Horizon Pharma (HZNP) Tops Q1 EPS by 15c

